Ball Corporation Beats Q1 Estimates, Reaffirms Full-Year 10%+ EPS Growth

Transcript intelligence

What changed

Q1 2026 comparable diluted EPS came in at $0.94 versus an estimated $0.845, an 11.2% surprise. Revenue of $3.60B exceeded the $3.34B consensus by 7.8%. Operating earnings grew 10% year over year, and the company achieved its 2x operating leverage target. Ball completed the Benepack acquisition, expanding EMEA capacity, and re-segmented its India and Myanmar plants into the EMEA segment for clearer reporting. The Millersburg, Oregon facility remains on track for full ramp-up in 2027 with $35M in start-up costs.

Guidance delta

Management reaffirmed all full-year guidance: 10%+ comparable EPS growth, over $900M free cash flow, and $800M in total shareholder returns. No changes to prior guidance. Capex outlook remains stable.

Key takeaways

• Q1 2026 volumes up ~1% YoY; comparable diluted EPS up 22% driven by 10% operating earnings growth.
• 2x operating leverage target achieved, supporting the 10%+ EPS growth outlook.
• Benepack acquisition completed, adding European capacity in Belgium and Hungary.
• Millersburg, Oregon facility on track for full ramp-up in 2027 with $35M start-up costs.
• Full-year guidance reaffirmed: >$900M FCF, $800M shareholder returns, 10%+ EPS growth.

Management priorities

• Ramping the Millersburg, Oregon plant toward full production by 2027.
• Integrating the Benepack acquisition to strengthen the European footprint.
• Expanding capacity in high-growth markets such as India.
• Focusing on profit per can as a core operating metric.
• Embedding EVA targets into plant-level incentive structures.